本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

思泰瑞医疗

235.70
-0.4900-0.21%
盘后235.700.00000.00%16:32 EDT
成交量:60.43万
成交额:1.42亿
市值:232.14亿
市盈率:36.10
高:237.05
开:234.70
低:232.20
收:236.19
52周最高:253.00
52周最低:200.98
股本:9,849.06万
流通股本:9,809.35万
量比:0.69
换手率:0.62%
股息:2.28
股息率:0.97%
每股收益(TTM):6.53
每股收益(LYR):6.24
净资产收益率:9.74%
总资产收益率:6.22%
市净率:3.34
市盈率(LYR):37.80

数据加载中...

2025/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/07/03

重要事件披露

Form 8-K - Current report
2025/06/25

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2025/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/14

重要事件披露

Form 8-K - Current report
2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/02/05

重要事件披露

Form 8-K - Current report
2024/11/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities